Clinical Trial Update: Negative Valence Brain Targets and Predictors of Anxiety and Depression Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating negative valence brain targets and predictors of anxiety and depression treatment for internalizing psychopathologie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Internalizing Psychopathologies
• Major Depressive Disorder

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Internalizing Psychopathologies (IPs) Depression and Anxiety | Phase 4 | Status: COMPLETED